Showing results 2 to 2 of 2
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial Journal:European Journal of Preventive Cardiology | 2021 | 25 |